
    
      The design of this study is a randomized, open, multi-center and control study. The patients
      with cerebral infarction are as the study objects. Coronal CT / MRI examination combined with
      NIHSS and Modified Ranking Scale, MMSE, Barthel index, Transcranial Doppler (TCD) examination
      are applied to evaluate the Vinpocetine treatment efficacy and safety for cerebral infarction
      [14]. From ethical side, all patients will receive a conventional therapy, and based on it,
      the test group will be given intravenous injection of Vinpocetine as add-on treatment.
      Observation period is 10-14 days, and follow up for 3 months.
    
  